Please ensure Javascript is enabled for purposes of website accessibility

Welcome to Regulatory Rapporteur. This site uses cookies. Read our policy.

  • Skip to main content
  • Skip to navigation
Site name
topra-logo

The Organisation for Professionals in Regulatory Affairs
Site name
Mast navigation
  • Become a member
  • Sign in
Search our site
Menu
Close menu
  • Regulatory Rapporteur - June 2025
  • Pharmaceuticals
    • Back to parent navigation item
    • Pharmaceuticals
    • Artificial intelligence
    • ATMP
    • Biologics
    • Chemistry, manufacturing and controls
    • Clinical trials
    • Non-clinical development
    • Oncology
    • Product information
    • Regulatory procedures
  • Veterinary
  • Medical devices
    • Back to parent navigation item
    • Medical devices
    • Combination products
    • In-vitro diagnostics
    • Software
    • Artificial intelligence
  • Industry news
    • Back to parent navigation item
    • Industry news
    • Industry news
      • Back to parent navigation item
      • Industry news
      • Read latest news
      • Video
  • Commentary
    • Back to parent navigation item
    • Commentary
    • Editorials
    • Letters to the Editor
    • Podcasts
  • Collections
    • Back to parent navigation item
    • Collections
    • Interviews
    • Symposium 2024
      • Back to parent navigation item
      • Symposium 2024
      • Annual lecture
    • Symposium 2023
      • Back to parent navigation item
      • Symposium 2023
      • Annual lecture
    • Symposium 2022
      • Back to parent navigation item
      • Symposium 2022
      • Annual lecture
    • Symposium 2021
      • Back to parent navigation item
      • Symposium 2021
      • Annual lecture
    • CPD supplements
      • Back to parent navigation item
      • CPD supplements
      • 2021/2022
      • 2020
      • 2019
  • JOIN TOPRA
  • topra-logo

    The Organisation for Professionals in Regulatory Affairs
  • Regulatory Rapporteur - June 2025
  • Pharmaceuticals
      • Artificial intelligence
      • ATMP
      • Biologics
      • Chemistry, manufacturing and controls
      • Clinical trials
      • Non-clinical development
      • Oncology
      • Product information
      • Regulatory procedures
    • FDAPLAT final
      ​Navigating the FDA’s platform technology designation: Key insights and best practices for drug manufacturers
    • ODD licensed image
      Navigating orphan drug designation in the EU
    • AIFORPV_final image
      Prescribing efficiency: Using generative artificial intelligence for pharmacovigilance
  • Veterinary
    • RR-June-2025-half cover _masthead
      June 2025 – Contents
    • June cover image licensed
      Veterinary medicines: Translating regulation into practice
    • RR-Nov-2024-Half-Cover
      November 2024 – Contents: Veterinary medicines sessions
    • SUSIMPERATIVE_compressed
      The sustainability imperative for the healthcare sector
  • Medical devices
      • Combination products
      • In-vitro diagnostics
      • Software
      • Artificial intelligence
    • MDR-innovation-compressed
      The EU Medical Device Regulation: Balancing innovation with regulation
    • final licensed cover image_compressed
      Medical device regulation: Challenges, innovation and the future
    • RR-Nov-2024-Half-Cover
      November 2024 – Contents: Medical devices/IVDs sessions
  • Industry news
      • Industry news
        • Read latest news
        • Video
    • animal test news licensed image
      ​FDA to replace animal testing with new approach methodologies
    • EMA VMR news licensed image
      EMA to address antimicrobial resistance risks from veterinary medicinal products
    • AdobeStock_232436477
      ​MHRA authorises new cancer treatment variation with significantly reduced administration time
  • Commentary
      • Editorials
      • Letters to the Editor
      • Podcasts
    • June cover image licensed
      Veterinary medicines: Translating regulation into practice
    • 6. cover image idea 6
      Advanced therapies: A maturing regulatory framework
    • TOPRA VetReg Podcast 800x533px (6.4 ratio)
      RegRapPod − InConversation with Ivo Claassen
  • Collections
      • Interviews
      • Symposium 2024
        • Annual lecture
      • Symposium 2023
        • Annual lecture
      • Symposium 2022
        • Annual lecture
      • Symposium 2021
        • Annual lecture
      • CPD supplements
        • 2021/2022
        • 2020
        • 2019
    • Banner_new
      Streamline medical device compliance with BSI Compliance NavigatorSponsored by The UK's National Standards Body
    • AdobeStock_59790119
      The Olaratumab experience
    • AdobeStock_207448226
      Qualification of stride velocity endpoint in Duchenne Muscular Dystrophy
  • JOIN TOPRA
  • More from navigation items

Pharmaceutical latest

  • TRUST final

    Sandbox of trust: Regulated AI for health promotion and disease prevention

    2025-06-06T14:07:00+01:00

  • FDAPLAT final

    ​Navigating the FDA’s platform technology designation: Key insights and best practices for drug manufacturers

    2025-05-02T13:42:00+01:00

  • AIFORPV_final image

    Prescribing efficiency: Using generative artificial intelligence for pharmacovigilance

    2025-05-02T13:42:00+01:00

  • ODD licensed image

    Navigating orphan drug designation in the EU

    2025-05-02T13:42:00+01:00

  • CANCER image final

    Recent advances and the near-term outlook for Advanced Therapy Medicinal Products in cancer treatment

    2025-05-02T13:41:00+01:00

  • 6. cover image idea 6

    Advanced therapies: A maturing regulatory framework

    2025-05-02T13:40:00+01:00



  • RR-May-2025-half_cover

    May 2025 – Contents

    2025-05-01T14:56:00+01:00

  • GTMP final

    ​Gene Therapy Medicinal Products: An examination of regulatory CMC requirements

    2025-05-01T09:43:00+01:00

  • RR-April-2025-half-cover

    April 2025 – Contents

    2025-04-03T14:48:00+01:00

  • licensed April issue cover

    Africa and the MENA region: Opportunities for growth

    2025-04-03T14:08:00+01:00

  • March half cover

    March 2025 – Contents

    2025-03-04T12:51:00+00:00

  • licensed front cover

    Data and AI: Readiness, research and real-world impact

    2025-03-04T12:22:00+00:00

  • licensed GPhC news story

    Pharmacies told to follow GPhC guidance on prescription-only weight-loss medicine

    2025-02-13T17:37:00+00:00

  • FOETALPIP

    Regulatory strategy implications for foetal medicine

    2025-02-07T12:35:00+00:00

  • Immune1 final licensed image

    Immunological considerations in the development of novel vaccines

    2025-02-07T12:35:00+00:00

  • RR-Feb-2025-half cover

    February 2025 – Contents

    2025-02-06T15:51:00+00:00

  • EPI Podcast 800x533px (6.4 ratio)

    RegRapPod − InConversation with the UK ePI Task Force

    2025-02-04T17:00:00+00:00

  • ROLEOFAI_final_compressed

    The role of artificial intelligence in regulatory affairs

    2025-01-10T08:54:00+00:00

More pharmaceutical content

  • What is Regulatory Affairs?
  • TOPRA Membership
  • Regulatory Rapporteur Editorial Board
  • Regulatory Rapporteur Editorial Area
  • Future Focus Topics
  • FAQs
  • Glossary
  • Privacy Policy
  • ISSN 2755-5070 (online)

    ISSN 1742-8955 (print - legacy)

Regulatory Rapporteur

The peer-reviewed journal, published 11 times per year and available free to TOPRA members.

Follow TOPRA
topra-logo

The Organisation for Professionals in Regulatory Affairs

TOPRA office
TOPRA Publishing, Third floor, City Reach, 5 Greenwich View Place, London E14 9NN, UK
Tel: +44 (0) 20 7510 2560
Email: publications@topra.org

TOPRA AISBL
Blvd du Souverain 280, 1160 Brussels, Belgium
Tel: +32 (0) 2 808 72 70

  • Contact us
  • Copyright © 2015-2025 The Organisation for Professionals in Regulatory Affairs Ltd. t/a Regulatory Rapporteur - All rights reserved

Site powered by Webvision Cloud